News Medical on MSN
Researchers engineer a tool to dismantle cancer's RNA-built growth hubs
In a city, coworking hubs bring people and ideas together. Inside cancer cells, similar hubs form-but instead of fueling progress, they supercharge disease. That's what researchers at the Texas A&M ...
Cancer cases and deaths are projected to surge in the coming decades with low and middle-income countries expected to bear a ...
22hon MSN
What is the extent of disparities in cancer clinical trials among low- and middle-income countries?
New research reveals that the number and complexity of cancer clinical trials since 2001 have varied across low- and ...
MedPage Today on MSN
SGLT2 Inhibitors Tied to Less Progression of Lung Lesions
SGLT2 is "highly expressed in early lung adenocarcinoma and its precursor lesions, including atypical adenomatous hyperplasia ...
After Anna, the wife of former soccer player Park Joo-ho, suffered from cancer, she felt grateful in her small daily lifeAnna ...
For oncologists, seeing more young patients also raises the question of what happens after treatment, and this prompted the ...
Discover Delcath’s innovative liver-targeted chemotherapy system and latest clinical data driving potential market expansion.
A dad has warned other blokes to never ignore unusual signs on their manhoods after a white spot on his penis developed into ...
Within the last two decades, multiple stem cell transplants and immunotherapy have been added to intensive chemotherapy as ...
Recently, there have been concerns around the surge of fraudulent loans and private credit quality issues in the US.
Scientists have identified two enzymes that help prostate cancer cells grow, survive and resist treatment, paving the way for new treatments.
Lirum Therapeutics, Inc. (“Lirum”), an innovative clinical-stage biopharmaceutical company focused on the treatment of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results